Ivan S. Coulter
Corporate Officer/Principal bei Irish Research Council
Aktive Positionen von Ivan S. Coulter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Irish Research Council | Corporate Officer/Principal | - | - |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Berater | 01.08.2022 | - |
Karriereverlauf von Ivan S. Coulter
Ehemalige bekannte Positionen von Ivan S. Coulter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Chief Investment Officer | 01.08.2018 | 02.12.2019 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2018 | 02.09.2018 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Vorstandsvorsitzender | 01.08.2003 | 02.05.2018 |
Technik-/Wissenschafts-/F&E-Leiter | 01.08.2003 | 02.05.2018 | |
Bord Iascaigh Mhara | Direktor/Vorstandsmitglied | 01.07.2007 | 02.08.2011 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | 01.01.2003 | - |
Vorstandsvorsitzender | 01.01.2003 | 23.05.2018 | |
Gründer | 01.01.2003 | - |
Ausbildung von Ivan S. Coulter
University College Dublin | Doctorate Degree |
Cornell University | Masters Business Admin |
Statistik
International
Irland | 6 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Irish Research Council | |
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Commercial Services |
Bord Iascaigh Mhara | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Finance |
- Börse
- Insiders
- Ivan S. Coulter
- Erfahrung